Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maideno Medical Technology Group is a leading Chinese medical device company focused on the research, development, and manufacturing of high-end interventional consumables. The company specializes in four core clinical fields: cardiovascular, neurovascular, peripheral vascular, and structural heart disease. Its product portfolio includes advanced tools such as balloon catheters, guide wires, and specialized interventional accessories designed for minimally invasive procedures. Maideno operates multiple R&D and manufacturing centers across China, aiming to provide high-quality, cost-effective solutions for complex vascular interventions. The group is backed by prominent venture capital firms and maintains a strong presence in the domestic interventional medicine market. Through its subsidiaries, the company continues to expand its pipeline into drug-coated balloons and neuro-interventional technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 迈得诺医疗科技集团.